Search for: "Parkinson's Disease"
Pfizer to Acquire FoldRx Pharmaceuticals
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Mergers & Acquisitions[Pfizer, FoldRx Pharmaceuticals]
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Regulatory[Archimedes Pharma, PecFent, fentanyl nasal spray, breakthrough cancer pain]
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
HSMN NewsFeed,
23 Aug 2010:
Biopharmaceuticals[Archimedes Pharma]
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
HSMN NewsFeed,
2 Aug 2010:
Biopharmaceuticals, Neurology, FDA[Merz Pharmaceuticals, Xeomin, incobotulinumtoxinA, cervical dystonia]
iPierian Closes $22 Million Series B Financing Led By Google Ventures
HSMN NewsFeed,
8 Jul 2010:
Biopharmaceuticals, Regenerative Medicine, Venture Capital[iPierian, stem cell]
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
HSMN NewsFeed,
18 Jun 2010:
Biopharmaceuticals[UCB, Neupro, rotigotine, Restless Legs Syndrome]
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
HSMN NewsFeed,
17 Jun 2010:
Biopharmaceuticals, Neurology[UCB, Neupro, rotigotine transdermal, Parkinson's Disease]
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
HSMN NewsFeed,
16 Jun 2010:
Biopharmaceuticals, Neurology[QR Pharma, Posiphen, Parkinson’s disease]
BrainStorm Announces Significant Milestones Achieved and 2009 Review
HSMN NewsFeed,
11 May 2010:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics]
Aton Pharma Acquires Parkinson's Drug LODOSYN(R) (carbidopa)
HSMN NewsFeed,
26 Apr 2010:
Biopharmaceuticals, Neurology, Acquisitions[Aton Pharma, Bristol-Myers Squibb, LODOSYN, carbidopa, Parkinson's disease]
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
HSMN NewsFeed,
23 Apr 2010:
Biopharmaceuticals, Drug Delivery, Neurology, FDA[UCB, Neupro, rotigotine, Parkinson's disease, restless legs syndrome]
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
HSMN NewsFeed,
15 Apr 2010:
Biopharmaceuticals, Neurology[Impax Pharmaceuticals, carbidopa, levodopa, Parkinson’s disease]
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
HSMN NewsFeed,
13 Apr 2010:
Biopharmaceuticals, Neurology[Baxter International, GAMMAGARD, Immune Globulin, Alzheimer’s disease]
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
HSMN NewsFeed,
13 Apr 2010:
Biopharmaceuticals, Neurology, Drug Delivery[UCB, Neupro, Rotigotine, Restless Legs Syndrome]
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
HSMN NewsFeed,
23 Mar 2010:
Biopharmaceuticals, FDA, Neurology[Boehringer Ingelheim Pharmaceuticals, Mirapex ER, Parkinson's disease]
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for World's Smallest Rechargeable Deep Brain Stimulator for Parkinson's Disease
HSMN NewsFeed,
23 Mar 2010:
Devices, Regulatory, Neurology[St. Jude Medical, deep brain stimulation, Brio DBS, neurostimulator, Parkinson]
FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy
HSMN NewsFeed,
12 Mar 2010:
Devices, Neurology, FDA[Medtronic, Deep Brain Stimulation, epilepsy]
Diamyd Medical: Diamyd US Phase III Study Well under Way
HSMN NewsFeed,
10 Mar 2010:
Biopharmaceuticals, Endocrinology[Diamyd Medical, DiaPrevent, Diamyd, diabetes]
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
HSMN NewsFeed,
23 Feb 2010:
Biopharmaceuticals, Regenerative Medicine, Personnel[iPierian, stem cell]
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
HSMN NewsFeed,
22 Feb 2010:
Biopharmaceuticals, Neurology, FDA[Boehringer Ingelheim, Mirapex, pramipexole, Parkinson's disease]
Medtronic: Advanced Deep Brain Stimulation Therapy Now Available in Canada
HSMN NewsFeed,
16 Feb 2010:
Devices, Neurology, Neurosurgery, Regulatory[Medtronic, Activa RC, Activa PC, neurostimulator, deep brain stimulation]
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
HSMN NewsFeed,
9 Feb 2010:
Diagnostics, Ophthalmology, Licensing[Sequenom, Optherion, SensiGene, macular degeneration]
Neuraltus Pharmaceuticals Names Andrew Gengos President and CEO
HSMN NewsFeed,
8 Feb 2010:
Biopharmaceuticals, Personnel[Neuraltus Pharmaceuticals]
AMT Announces Management Changes in Light of Refocused Strategy
HSMN NewsFeed,
2 Dec 2009:
Biopharmaceuticals, Personnel[Amsterdam Molecular Therapeutics, Glybera]
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
HSMN NewsFeed,
1 Dec 2009:
Biopharmaceuticals, Neurology, Mergers & Acquisitions[DiaMedica, Sanomune, Alzheimer's disease, diabetes, HbA1c]
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
HSMN NewsFeed,
2 Nov 2009:
Devices, Endocrinology[Pico-Tesla Magnetic Therapies, Resonator, Magneceutical, diabetes]
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
HSMN NewsFeed,
12 Oct 2009:
Biopharmaceuticals, Licensing[Novartis, Novartis Pharma AG, Vanda Pharmaceuticals, Fanapt, iloperidone]
Pico-Tesla Starts Phase III Clinical Trial of Its Proprietary Magnetic (Magneceutical) Therapy for Parkinson's Disease
HSMN NewsFeed,
5 Oct 2009:
Devices, Neurology[Pico-Tesla Magnetic Therapies, Resonator, Magneceutical, Parkinson’s disease]
Abbott to Acquire Solvay Pharmaceuticals Business
HSMN NewsFeed,
28 Sep 2009:
Biopharmaceuticals, Mergers & Acquisitions[Abbott, Solvay Pharmaceuticals]
St. Jude Medical Receives CE Mark Approval for World's Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson's Disease
HSMN NewsFeed,
9 Sep 2009:
Devices, Neurology, Regulatory[St. Jude Medical, Brio neurostimulator, deep brain stimulation, Parkinson’s]
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
HSMN NewsFeed,
3 Sep 2009:
Biopharmaceuticals, Neurology, Personnel[Satori Pharmaceuticals]
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
HSMN NewsFeed,
1 Sep 2009:
Biopharmaceuticals, Neurology[ACADIA Pharmaceuticals, Pimavanserin, Parkinson’s disease]
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
HSMN NewsFeed,
31 Aug 2009:
Devices, Neurosurgery[Integra LifeSciences, MAYFIELD Infinity XR2, Radiolucent Cranial Stabilization]
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
HSMN NewsFeed,
25 Aug 2009:
Biopharmaceuticals, Personnel[Adamas Pharmaceuticals]
Adamas Pharmaceuticals Raises $40 Million in Series D Financing
HSMN NewsFeed,
18 Aug 2009:
Biopharmaceuticals, Venture Capital, Personnel[Adamas Pharmaceuticals]
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
HSMN NewsFeed,
5 Aug 2009:
Biopharmaceuticals, Neurology[Ceregene, CERE-120, Parkinson's disease]
Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
HSMN NewsFeed,
16 Jul 2009:
Devices, Neurology, FDA[Medtronic, Deep Brain Stimulation, epilepsy, SANTE study]
St. Jude Medical Announces Australian TGA Regulatory Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
HSMN NewsFeed,
14 Jul 2009:
Devices, Neurology, Regulatory[St. Jude Medical, deep brain stimulation, Parkinson’s disease, essential tremor]
A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders
HSMN NewsFeed,
14 Jul 2009:
Devices, Neurosurgery[InSightec, Focused Ultrasound, neuropathic pain]
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly Improved Early Morning akinesia and was Generally Well Tolerated Over Four Years
HSMN NewsFeed,
12 Jun 2009:
Biopharmaceuticals, Neurology[UCB, rotigotine, Neupro , Parkinson's Disease]
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson's Disease
HSMN NewsFeed,
8 Jun 2009:
Devices, Neurology[St. Jude Medical, deep brain stimulation, Libra , LibraXP, Parkinson’s disease]
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
HSMN NewsFeed,
29 May 2009:
Biopharmaceuticals, Neurology, Regulatory[UCB, Neupro, rotigotine transdermal patch, Parkinson's disease]
Power3 Medical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer's
HSMN NewsFeed,
28 May 2009:
Diagnostics, Neurology[Power3 Medical Products, NuroPro, Alzheimer's disease]
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
HSMN NewsFeed,
18 May 2009:
Diagnostics, Neurology[Power3 Medical Products, NuroPro, Parkinson's disease]
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
HSMN NewsFeed,
18 May 2009:
Biopharmaceuticals, FDA[Janssen Pharmaceuticals, RISPERDAL, risperidone, Bipolar Disorder]
Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy
HSMN NewsFeed,
14 May 2009:
Biopharmaceuticals, Neurology[Asubio Pharmaceuticals, Piclozotan, Parkinson's Disease]
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
HSMN NewsFeed,
11 May 2009:
Diagnostics, Neurology[Transgenomic, Power3 Medical Products, NuroPro , Alzheimer's, Parkinson's]
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
HSMN NewsFeed,
8 May 2009:
Biopharmaceuticals, Drug Delivery, Oncology[Archimedes Pharma, NasalFent, fentanyl, breakthrough cancer pain]
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
HSMN NewsFeed,
7 May 2009:
Biopharmaceuticals, Neurology[Merck Serono, Merck KGaA, Newron Pharmaceuticals, safinamide, SETTLE study]
Teva Announces Extension of Patent Protection for Azilect
HSMN NewsFeed,
6 May 2009:
Biopharmaceuticals, Neurology, Generics[Teva Pharmaceutical, Azilect, Parkinson's disease]
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
HSMN NewsFeed,
15 Apr 2009:
Biopharmaceuticals, Neurology, Venture Capital[Accera, Neuera Pharmaceuticals]
New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
HSMN NewsFeed,
10 Apr 2009:
Biopharmaceuticals, Neurology[UCB, Keppra XR, levetiracetam, epilepsy]
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
HSMN NewsFeed,
26 Mar 2009:
Biopharmaceuticals, Neurology, Venture Capital[Neuraltus Pharmaceuticals, Amyotropic Lateral Sclerosis, Parkinson's Disease]
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
HSMN NewsFeed,
18 Mar 2009:
Diagnostics, Neurology[Power3 Medical Products, NuroPro, BC-SeraPro, Alzheimer’s, Parkinson’s disease]
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
HSMN NewsFeed,
3 Feb 2009:
Biopharmaceuticals, Neurology[Merck Serono, Merck KGaA, Newron, Safinamide, Parkinson's Disease]
St. Jude Medical Announces European CE Mark Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
HSMN NewsFeed,
26 Jan 2009:
Devices, Neurology, Regulatory[St. Jude Medical, Libra , LibraXP, deep brain stimulation]
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
HSMN NewsFeed,
9 Jan 2009:
Biopharmaceuticals, Neurology, FDA[GlaxoSmithKline, XenoPort, Solzira, gabapentin, Restless Legs Syndrome]
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed,
8 Jan 2009:
Biopharmaceuticals, Neurology, Venture Capital, Personnel[Satori Pharmaceuticals, Alzheimer's disease, Parkinson's disease]
Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
HSMN NewsFeed,
12 Nov 2008:
Devices, Neurology, Venture Capital[Intelect Medical, Boston Scientific, Greatbatch, neuromodulation]
GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
HSMN NewsFeed,
21 Oct 2008:
Biopharmaceuticals, Acquisitions[GlaxoSmithKline, Laclede, Biotene]
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Generics, FDA[Mylan, Carbidopa, Levodopa, Schwarz Pharma, Parcopa, Parkinson's disease]
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
HSMN NewsFeed,
21 Sep 2008:
Devices[Coapt Systems, Novielle Voice Gel]
The European Commission Grants Orphan Drug Designation to Alseres Pharmaceuticals' Spinal Cord Injury Treatment, Cethrin(R)
HSMN NewsFeed,
18 Sep 2008:
Biopharmaceuticals, Neurology, Regulatory[Alseres Pharmaceuticals, Cethrin, orphan drug designation]
GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
HSMN NewsFeed,
16 Sep 2008:
Biopharmaceuticals[GlaxoSmithKline, XenoPort, Solzira, gabapentin enacarbil, Restless Legs Syndrome]
Keppra XR(TM) Approved in the U.S.
HSMN NewsFeed,
15 Sep 2008:
Biopharmaceuticals, Neurology, FDA[UCB, Keppra XR, levetiracetam, epilepsy]
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
HSMN NewsFeed,
12 Sep 2008:
Diagnostics, Personnel[Power3 Medical Products]
ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
HSMN NewsFeed,
26 Aug 2008:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, ADAGIO trial, Parkinson's disease, AZILECT, rasagiline]
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals, Personnel[Marinus Pharmaceuticals]
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
Medtronic Launches First Insertable Cardiac Monitor in Japan
HSMN NewsFeed,
15 Jul 2008:
Devices, Cardiology, Monitoring, Regulatory[Medtronic, Reveal DX, Insertable Cardiac Monitor, syncope]
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
HSMN NewsFeed,
13 Jun 2008:
Biopharmaceuticals, Neurology, FDA[GlaxoSmithKline, Requip XL, ropinirole, Parkinson's disease]
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Mirapexin, Sifrol, Restless Legs Syndrome]
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
HSMN NewsFeed,
23 May 2008:
Biopharmaceuticals, FDA[Osmotica Pharmaceutical, Venlafaxine, Effexor XR, Wyeth]
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
HSMN NewsFeed,
22 May 2008:
Biopharmaceuticals, Neurology[Myriad Genetics, Lundbeck, Flurizan, Alzheimer's disease]
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
HSMN NewsFeed,
25 Apr 2008:
Biopharmaceuticals, Regulatory[UCB, Neupro, rotigotine transdermal patch, Restless Legs Syndrome]
Ceregene Announces Two Key Additions to Leadership Team
HSMN NewsFeed,
23 Apr 2008:
Biopharmaceuticals, Personnel[Ceregene]
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
HSMN NewsFeed,
17 Apr 2008:
Biopharmaceuticals, Diagnostics, Neurology[Alseres Pharmaceuticals, ALTROPANE, Parkinson's Disease, Essential Tremor]
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
HSMN NewsFeed,
17 Apr 2008:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Mirapexin, Sifrol, Restless Legs Syndrome]
Medtronic Activa(R) Deep Brain Stimulation Patient Referral Advisor Software Launched in United States
HSMN NewsFeed,
16 Apr 2008:
Devices, Neurology[Medtronic, Activa DBS, Patient Referral Advisor, Parkinson’s disease]
Vasogen Announces Implementation of Strategic Restructuring Plan
HSMN NewsFeed,
14 Apr 2008:
Biopharmaceuticals[Vasogen, Celacade]
Stem Cells From Menstrual Blood Show Therapeutic Potential
HSMN NewsFeed,
14 Apr 2008:
Regenerative Medicine[Cryo-Cell International, Menstrual stem cells, stem cell]
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
HSMN NewsFeed,
11 Apr 2008:
Biopharmaceuticals[Eisai, E2007, perampanel, AMPA receptor]
ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals[ACADIA Pharmaceuticals, pimavanserin, Parkinson’s disease]
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
HSMN NewsFeed,
20 Mar 2008:
Biopharmaceuticals, Neurology, Product Recall[UCB, Neupro , rotigotine, rotigotine transdermal system, Parkinson's disease]
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
HSMN NewsFeed,
27 Feb 2008:
Biopharmaceuticals, Neurology, FDA[Kyowa Hakko Kogyo, Kyowa Pharmaceutical, istradefylline, KW-6002, Parkinson's]
Integra LifeSciences Introduces Titanium Skull Pins for Intra-Operative Brain Surgery
HSMN NewsFeed,
27 Feb 2008:
Devices, Neurosurgery[Integra LifeSciences, MAYFIELD, skull pins]
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
HSMN NewsFeed,
19 Feb 2008:
Biopharmaceuticals, Generics, FDA[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Mirapex]
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
HSMN NewsFeed,
18 Feb 2008:
Biopharmaceuticals, FDA, Neurology[Solvay Pharmaceuticals, levodopa/carbidopa, intestinal gel, Parkinson's disease]
Chelsea Therapeutics Begins Patient Dosing in Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension
HSMN NewsFeed,
7 Feb 2008:
Biopharmaceuticals[Chelsea Therapeutics, Droxidopa, orthostatic hypotension]
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
HSMN NewsFeed,
23 Jan 2008:
Diagnostics, Personnel[Molecular Biometrics, metabolomics]
Amarin Announces Management Changes Including Appointment of New CEO
HSMN NewsFeed,
19 Dec 2007:
Biopharmaceuticals, Personnel[Amarin Corp]
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Neurology, FDA[Neurologix, Parkinson’s disease, Neurologix gene transfer, gene therapy]
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Neurology[UCB, Neupro, Rotigotine, Parkinson's disease]
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Neurology[UCB, Neupro, rotigotine, restless legs syndrome]
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
HSMN NewsFeed,
6 Dec 2007:
Biopharmaceuticals, Personnel[Ceregene]
Amarin Signs Agreement to Acquire Ester Neurosciences
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals, Neurology, Mergers & Acquisitions[Amarin Corp, Ester Neurosciences]
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals, Regulatory[UCB, Neupro , rotigotine transdermal patch, Restless Legs Syndrome]
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
HSMN NewsFeed,
20 Nov 2007:
Regenerative Medicine, Neurology, Licensing[Neuralstem, stem cell]
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
HSMN NewsFeed,
19 Nov 2007:
Biopharmaceuticals, Neurology[Amarin Corp, Miraxion, Huntington's disease, TREND-HD trial]
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed,
12 Nov 2007:
Biopharmaceuticals, FDA[Chelsea Therapeutics, Droxidopa, orthostatic hypotension]
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
HSMN NewsFeed,
12 Nov 2007:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics, stem cell]
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, Personnel[Acologix]
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Generics, FDA[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Mirapex]
Neurogen Corporation Announces Appointment of Kenneth J. Sprenger to Vice President, Clinical Development and Operations
HSMN NewsFeed,
17 Oct 2007:
Biopharmaceuticals, Personnel[Neurogen]
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
HSMN NewsFeed,
16 Oct 2007:
Biopharmaceuticals, Neurology, Personnel[Cortex Pharmaceuticals]
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals, Neurology, Personnel[Accera, Ketasyn, Alzheimer's disease]
Amarin Announces Initiation of Cardiovascular Development Strategy
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals[Amarin , dyslipidemia, metabolic syndrome]
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals, Personnel[NuPathe]
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
HSMN NewsFeed,
8 Oct 2007:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics, Amyelotrophic Lateral Sclerosis, stem cell]
AVANIR Granted Special Protocol Assessment (SPA) From FDA for Confirmatory Phase III Trial of Zenvia in Patients With PBA
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology[AVANIR Pharmaceuticals, Zenvia, dextromethorphan, quinidine, pseudobulbar affect]
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology, Drug Delivery[UCB, rotigotine, restless legs syndrome]
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology, Drug Delivery[UCB, Neupro, Rotigotine, dopamine agonist patch, Parkinson's disease]
Santhera Announces Start of US Phase III Clinical Trial with SNT-MC17 in Friedreich's Ataxia and Provides Details on Study Design
HSMN NewsFeed,
28 Sep 2007:
Biopharmaceuticals, Neurology, FDA[Santhera Pharmaceuticals, SNT-MC17, idebenone, Friedreich's Ataxia, Ataxia]
EnVivo Pharmaceuticals Announces Executive Appointment
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel[EnVivo Pharmaceuticals]
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel[Titan Pharmaceuticals]
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
HSMN NewsFeed,
24 Sep 2007:
Biopharmaceuticals, Neurology[Alseres Pharmaceuticals, spinal cord injury, Cethrin]
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
HSMN NewsFeed,
19 Sep 2007:
Regenerative Medicine, Neurology, Litigation[Neuralstem, StemCells, stem cell]
Valeant Pharmaceuticals Announces the Launch of the zelaCARD for Parkinson's Disease Patients Taking Zelapar(R)
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, Neurology[Valeant Pharmaceuticals, Zelapar, zelaCARD, Parkinson's disease]
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
HSMN NewsFeed,
14 Sep 2007:
Biopharmaceuticals, Personnel[Neurogen]
BrainStorm Cell Therapeutics Takes Initial Steps Toward FDA Submission
HSMN NewsFeed,
10 Sep 2007:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics, stem cell, Parkinson's Disease]
Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
HSMN NewsFeed,
30 Aug 2007:
Biopharmaceuticals, Personnel[Prestwick Pharmaceuticals]
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
HSMN NewsFeed,
30 Aug 2007:
Biopharmaceuticals, Personnel[Neurogen]
Prestwick Pharmaceuticals, Inc. Strengthens Management Team with Appointment of Robert S. Radie as Chief Business Officer
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Personnel[Prestwick Pharmaceuticals]
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
HSMN NewsFeed,
16 Aug 2007:
Biopharmaceuticals, Neurology, Regulatory[Santhera Pharmaceuticals, Takeda Pharmaceutical, idebenone, SNT-MC17, Ataxia]
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
HSMN NewsFeed,
14 Aug 2007:
Biopharmaceuticals, Regulatory[Chelsea Therapeutics, Droxidopa, orthostatic hypotension]
Stem Cell Therapy International Acquires Exclusive Worldwide Rights to New, Anti-Rejection Stem Cell Technology
HSMN NewsFeed,
2 Aug 2007:
Regenerative Medicine[Stem Cell Therapy International, stem cell]
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
HSMN NewsFeed,
31 Jul 2007:
Biopharmaceuticals, Acquisitions, Neurology[Neuren Pharmaceuticals, Motiva , Hamilton Pharmaceuticals]
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
HSMN NewsFeed,
30 Jul 2007:
Biopharmaceuticals, Devices, Drug Delivery, Neurology[Alnylam Pharmaceuticals, Medtronic, RNA Interference, Huntington's disease]
NeuroDerm Raises $2.5 Million in Series A Financing
HSMN NewsFeed,
23 Jul 2007:
Biopharmaceuticals, Venture Capital[NeuroDerm]
Panacea Pharmaceuticals Announces the Availability of LC Detect(sm), a Serum-Based Diagnostic Test for Lung Cancer
HSMN NewsFeed,
17 Jul 2007:
Diagnostics, Oncology[Panacea Pharmaceuticals, LC Detect, lung cancer]
UCB Announces the U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
HSMN NewsFeed,
16 Jul 2007:
Biopharmaceuticals, Neurology[UCB, SCHWARZ PHARMA, Neupro , Rotigotine, Parkinson's disease]
BrainStorm Cell Therapeutics Elects Moshe Lion to Its Board of Directors
HSMN NewsFeed,
16 Jul 2007:
Regenerative Medicine, Personnel[BrainStorm Cell Therapeutics, stem cell]
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
HSMN NewsFeed,
16 Jul 2007:
Biopharmaceuticals, Neurology[SCHWARZ PHARMA, UCB, Rotigotine, Transdermal System, Neupro, Parkinson's disease]
Avicena to Advance Huntington's Disease Clinical Program into Phase III
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Neurology[Avicena Group, HD-02, Huntington's Disease]
Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson's Disease
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Neurology[Titan Pharmaceuticals, Spheramine, Parkinson's disease]
Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
HSMN NewsFeed,
27 Jun 2007:
Biopharmaceuticals, Neurology, FDA[Alseres Pharmaceuticals, Boston Life Sciences, Cethrin, spinal cord injury]
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Neurology[Neurologix, Parkinson's disease, gene therapy]
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Neurology[Genzyme, Ceregene, CERE-120, Parkinson's disease]
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Radiology[Avid Radiopharmaceuticals, Bayer Schering Pharma, 18F-AV1/ZK, imaging]
Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Neurology[Memory Pharmaceuticals, MEM 3454, Schizophrenia]
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
HSMN NewsFeed,
18 Jun 2007:
Diagnostics, Biopharmaceuticals, Neurology[Gene Logic, Parkinson's disease]
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
HSMN NewsFeed,
18 Jun 2007:
Biopharmaceuticals, FDA[Cephalon, NUVIGIL, armodafinil]
Washington Hospital Healthcare System First in the United States to Treat Patients Using the New Leksell(R) Gamma Knife Perfexion(TM)
HSMN NewsFeed,
12 Jun 2007:
Devices, Oncology, Neurosurgery[Elekta, Leksell, Gamma Knife Perfexion, radiosurgery]
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
HSMN NewsFeed,
11 Jun 2007:
Devices, Neurology, Venture Capital[Intelect Medical, neuromodulation]
Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc.
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals[Boston Life Sciences, Alseres Pharmaceuticals]
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals, Neurology[Teva Neuroscience, Parkinson's disease, AZILECT, rasagiline]
In 2009 Exonhit Aims to ask for Market Clearance in Europe for a Blood Diagnostic Test for Alzheimer's Disease
HSMN NewsFeed,
7 Jun 2007:
Diagnostics, Neurology[ExonHit Therapeutics, Alzheimer's disease]
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, Oxford BioMedica , TroVax, renal cell carcinoma]
Panacea Pharmaceuticals Announces the Availability of PC Detect(sm) for Prostate Cancer Screening
HSMN NewsFeed,
31 May 2007:
Diagnostics, Oncology[Panacea Pharmaceuticals, Panacea Laboratories, PC Detect, prostate cancer]
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
HSMN NewsFeed,
30 May 2007:
Regenerative Medicine[Neuralstem, stem cell]
Neuro-Hitech, Inc., Obtains Exclusive License to Combination Drugs for the Treatment of Alzheimer's Disease and Other Serious Neurological Disorders
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Neurology, Licensing[Neuro-Hitech, Huperzine, Alzheimer's disease, Parkinson's disease]
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Personnel[Boston Life Sciences]
New Agreement Boosts Pipeline for Synosia Therapeutics
HSMN NewsFeed,
22 May 2007:
Biopharmaceuticals, Licensing[Synosia Therapeutics, Syngenta]
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
HSMN NewsFeed,
17 May 2007:
Devices, Personnel[CVRx, Rheos, Baroreflex Hypertension Therapy]
NeuroVista Raises $33.8 Million in Series B Financing
HSMN NewsFeed,
10 May 2007:
Devices, Neurology, Venture Capital[NeuroVista, BioNeuronics, epilepsy]
FDA Approves SCHWARZ PHARMA's Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
HSMN NewsFeed,
10 May 2007:
Biopharmaceuticals, Drug Delivery, Neurology, FDA[SCHWARZ PHARMA, Neupro, Rotigotine Transdermal System, Parkinson's disease]
Avid Radiopharmaceuticals Closes $26 Million Series C Financing
HSMN NewsFeed,
9 May 2007:
Biopharmaceuticals, Radiology, Neurology, Venture Capital[Avid Radiopharmaceuticals]
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
HSMN NewsFeed,
8 May 2007:
Biopharmaceuticals, Neurology[Vernalis, Biogen Idec, BIIB014, V2006, Parkinson's disease,]
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals, Neurology[Ceregene, CERE-110, Alzheimer's disease]
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals[Neurogen, NGD-4715, MCHR1, obesity]
CleveMed Receives FDA Clearance to Market Wireless Movement Disorder Monitor
HSMN NewsFeed,
1 May 2007:
Devices, Neurology, Monitoring[CleveMed, Kinesia, ParkinSense]
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
HSMN NewsFeed,
30 Apr 2007:
Devices, Neurosurgery, Oncology[Elekta, Gamma Knife, Perfexion]
Meda Acquires Product Portfolio from the US Pharma Company Wyeth
HSMN NewsFeed,
27 Apr 2007:
Biopharmaceuticals, Acquisitions[Meda AB, Wyeth]
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Neurology[Amarin Corp, Miraxion, Huntington's Disease]
William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors
HSMN NewsFeed,
24 Apr 2007:
Regenerative Medicine, Neurology, Personnel[Neuralstem, stem cell]
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases after Receiving CLIA High-Complexity Certification
HSMN NewsFeed,
19 Apr 2007:
Diagnostics, Personnel[Power3 Medical Products]
Integra LifeSciences Releases New Brain Mapping Software to Treat Parkinson's Disease
HSMN NewsFeed,
17 Apr 2007:
Devices, Neurology[Integra LifeSciences, Radionics, NeuroSight Arc, Parkinson's Disease]
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Neurology[SCHWARZ PHARMA, Rotigotine, PREFER Study, Parkinson's disease]
Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Neurology[Boston Life Sciences, Cethrin, nerve repair therapy, Rho Inhibitor]
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Personnel[Boston Life Sciences]
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
HSMN NewsFeed,
13 Apr 2007:
Biopharmaceuticals, Neurology[Ceregene, CERE-120, Parkinson's disease]
Medtronic Wins Medical Design Excellence Awards for Products Related to Activa(R) Deep Brain Stimulation Therapy and Ear, Nose and Throat Surgery
HSMN NewsFeed,
12 Apr 2007:
Devices[Medtronic, Activa , Deep Brain Stimulation, Nexframe, Stimloc, LandmarX]
Amarin Appoints Declan Doogan to New Position of President-Research and Development
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Personnel[Amarin Corp]
John Conron Joins Neuralstem as Chief Financial Officer
HSMN NewsFeed,
10 Apr 2007:
Regenerative Medicine, Neurology, Personnel[Neuralstem, stem cell]
Exciting Developments on the Horizon for Parkinson Disease, Says Medical Director for the National Parkinson Foundation
HSMN NewsFeed,
6 Apr 2007:
Biopharmaceuticals, Regenerative Medicine, Neurology[Parkinson disease, Parkinson's disease]
One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United States
HSMN NewsFeed,
5 Apr 2007:
Biopharmaceuticals, Neurology[Avicena Group, Parkinson's disease, PD-02, NET-PD]
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
HSMN NewsFeed,
3 Apr 2007:
Biopharmaceuticals, Personnel[Amarin Corp]
Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa
HSMN NewsFeed,
2 Apr 2007:
Biopharmaceuticals, Neurology[GlaxoSmithKline, REQUIP, ropinirole, Parkinson Disease]
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
HSMN NewsFeed,
30 Mar 2007:
Biopharmaceuticals, FDA[Cephalon, NUVIGIL, armodafinil]
Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of Directors
HSMN NewsFeed,
22 Mar 2007:
Devices, Personnel[Boston Life Sciences]
Avicena Announces Patient Enrollment in National Institutes of Health (NIH) Phase III Parkinson's Disease Trial
HSMN NewsFeed,
22 Mar 2007:
Biopharmaceuticals, Neurology[Avicena Group, PD-02, Parkinson's disease, creatine]
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Radiology, Neurology[Avid Radiopharmaceuticals, AV-1, Alzheimer's disease, ß-amyloid, imaging]
Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Neurology[Medivation, Dimebon, Alzheimer's disease]
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Drug Delivery[Vyteris, LidoSite]
Neuralstem Inc. Raises $5 Million in a Private Placement
HSMN NewsFeed,
16 Mar 2007:
Regenerative Medicine, Neurology[Neuralstem]
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
HSMN NewsFeed,
6 Mar 2007:
Biopharmaceuticals, Drug Delivery, Neurology, Licensing[Amarin Corp, Lorazepam, NanoCrystal, Elan Corp, Epilepsy]
Amarin Appoints Professor William Hall as Non-Executive Director
HSMN NewsFeed,
27 Feb 2007:
Biopharmaceuticals, Neurology, Personnel[Amarin Corp]
Cardiome Announces Management Appointments
HSMN NewsFeed,
22 Feb 2007:
Biopharmaceuticals, Cardiology, Personnel[Cardiome Pharma]
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
HSMN NewsFeed,
22 Feb 2007:
Biopharmaceuticals, Regenerative Medicine, Personnel[VistaGen Therapeutics, stem cell]
Vyteris Announces Senior Staff Promotions
HSMN NewsFeed,
20 Feb 2007:
Devices, Drug Delivery, Personnel[Vyteris]
Amarin Announces Completion of Two Phase III Trials With Miraxion in Huntington's Disease
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Neurology[Amarin Corp, Miraxion, ethyl-EPA, Huntington's Disease]
Proneuron Announces the Receipt of a $430,000 Grant from the Michael J. Fox Foundation to Develop Its PN277 for the Treatment of Parkinson's Disease
HSMN NewsFeed,
24 Jan 2007:
Biopharmaceuticals, Neurology[Proneuron Biotechnologies, Parkinson's disease]
Amicus Therapeutics Receives Grant From Michael J. Fox Foundation for Parkinson's Research
HSMN NewsFeed,
23 Jan 2007:
Biopharmaceuticals, Neurology[Amicus Therapeutics, pharmacological chaperone, Parkinson's disease]
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
HSMN NewsFeed,
19 Jan 2007:
Biopharmaceuticals, Radiology, Licensing[Bayer Schering Pharma, Taisho Pharmaceutical, Nihon Nohyaku, imaging]
Neuralstem Licenses Out Compounds for Diabetes Treatment
HSMN NewsFeed,
11 Jan 2007:
Regenerative Medicine, Licensing[Neuralstem, neural stem cells]
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
HSMN NewsFeed,
10 Jan 2007:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exclusive Worldwide License
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals, Neurology, Licensing[Boston Life Sciences, BioAxone Therapeutic, Cethrin, acute spinal cord injury]
SCHWARZ PHARMA Announces Publication of Rotigotine Data in Neurology
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Drug Delivery, Neurology[SCHWARZ PHARMA, rotigotine, Parkinson's disease]
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
HSMN NewsFeed,
22 Dec 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Parkinson's disease, ADAGIO study, AZILECT, rasagiline]
Avicena Signs Agreement with the National Institute of Neurological Disorders and Stroke for Phase III Trial for Novel Parkinson's Disease Candidate
HSMN NewsFeed,
6 Dec 2006:
Biopharmaceuticals, Neurology[Avicena Group, PD-02, Parkinson's disease]
Stem Cell Therapy International Reports the Successful Treatment of a Stroke Patient With Their Proprietary Stem Cell Transplantation Therapy
HSMN NewsFeed,
29 Nov 2006:
Regenerative Medicine, Neurology[Stem Cell Therapy International, stem cell, stroke]
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
HSMN NewsFeed,
28 Nov 2006:
Biopharmacetuicals, Licensing[Neurogen , Wyeth, Aplindore, Parkinson's disease, restless legs syndrome]
Neuro-Hitech Announces Agreement to Acquire Q-RNA, Inc.
HSMN NewsFeed,
17 Nov 2006:
Biopharmaceuticals, Neurology, Mergers & Acquisitions[Neuro-Hitech, Q-RNA Inc]
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
HSMN NewsFeed,
10 Nov 2006:
Biopharmaceuticals, FDA[Boehringer Ingelheim, MIRAPEX, pramipexole, Restless Legs Syndrome]
Raptor Pharmaceuticals Corp. Announces an Exclusive Worldwide License Agreement for Mesd Reagents for Treatment of Cancer and Osteoporosis
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, Licensing[Raptor Pharmaceutical, Mesd reagent]
Gladstone Institutes and Merck & Co., Inc. Announce Major Research Collaboration and Exclusive License Agreement in Field of Apolipoprotein (Apo) E
HSMN NewsFeed,
2 Nov 2006:
Biopharmaceuticals, Neurology, Licensing[Merck, Apolipoprotein, Alzheimer's Disease]
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, pramipexole, Parkinson's disease]
Stem Cell Treatment Proven to Reduce Parkinson's Symptoms
HSMN NewsFeed,
24 Oct 2006:
Regenerative Medicine, Neurology[Retinal Pigment Epithelial cells, stem cell, Parkinson's disease]
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
HSMN NewsFeed,
16 Oct 2006:
Biopharmaceuticals, Neurology, Licensing[Serono, Newron Pharmaceuticals, safinamide, Parkinson's disease]
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
HSMN NewsFeed,
11 Oct 2006:
Diagnostics, Neurology[Osta Biotechnologies, Parkinson's disease, Alzheimer's disease]
New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, Neurology[Novartis, FTY720, fingolimod, multiple sclerosis]
Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent
HSMN NewsFeed,
25 Sep 2006:
Biopharmaceuticals, Radiology, Neurology[Boston Life Sciences, ALTROPANE, Imaging Agent, Parkinson's Disease]
Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
NuPathe Closes $15 Million Financing
HSMN NewsFeed,
13 Sep 2006:
Biopharmaceuticals, Venture Capital[NuPathe]
Omeros Acquires Nura
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Mergers & Acquisitions[Omeros , Nura Inc]
SCHWARZ PHARMA's Parkinson Patch Offers Additional Benefits
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals, Drug Delivery, Neurology[Schwarz Pharma, Neupro, rotigotine transdermal patch, Parkinson's disease]
New Study Reveals Investigational 24-Hour Formulation of Requip(R) (ropinirole HCl) Tablets Reduced "Off" Time for Patients With Parkinson's Disease
HSMN NewsFeed,
4 Sep 2006:
Biopharmaceuticals, Neurology[GlaxoSmithKline, Requip, ropinirole, Parkinson's Disease]
New England Journal of Medicine Reports Superior Benefits of Deep Brain Stimulation for Advanced Parkinson's Disease
HSMN NewsFeed,
30 Aug 2006:
Devices, Neurology[Medtronic, Activa , Deep Brain Stimulation, Parkinson's disease]
Pramipexole Safe and Effective in Treating Restless Legs Syndrome, Study Shows
HSMN NewsFeed,
24 Aug 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, pramipexole, restless legs syndrome]
New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
HSMN NewsFeed,
23 Aug 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, Mirapex, pramipexole, Parkinson's disease]
Prestwick Pharmaceuticals Appoints George F. Horner III as President and Chief Executive Officer
HSMN NewsFeed,
22 Aug 2006:
Biopharmaceuticals, Personnel[Prestwick Pharmaceuticals]
Teva Announces Health Canada Approves AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed,
21 Aug 2006:
Biopharmaceuticals, Neurology, Regulatory[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's disease]
Teva Neuroscience Announces AZILECT(R) Is Now Available in Pharmacies - the First, Once-Daily Treatment for Parkinson's Disease
HSMN NewsFeed,
31 Jul 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's Disease]
Amarin Completes Target Patient Enrollment in European Phase III Trial of Miraxion(TM) in Huntington's Disease
HSMN NewsFeed,
27 Jul 2006:
Biopharmaceuticals, Neurology[Amarin , Miraxion, Huntington's disease]
Stem Cell Authority Ltd.(TM) Offers Ethical Alternative to Alleviate Political Stem Cell Deadlock Between U.S. Congress and President
HSMN NewsFeed,
20 Jul 2006:
Regenerative Medicine[Stem Cell Authority, Wharton's Jelly, stem cell]
SmartPill Wins 510(k) Release from FDA
HSMN NewsFeed,
20 Jul 2006:
Devices, Gastroenterology, FDA[SmartPill Corp, SmartPill]
Stem Cell Therapy International Names Lixian (John) Jiang, Chief Operating Officer, China Division
HSMN NewsFeed,
20 Jul 2006:
Regenerative Medicine, Personnel[Stem Cell Therapy International]
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
HSMN NewsFeed,
19 Jul 2006:
Biopharmaceuticals, Neurology[Novartis, Exelon, rivastigmine, Alzheimer's disease]
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
HSMN NewsFeed,
18 Jul 2006:
Biopharmaceuticals, Drug Delivery, Neurology[Valeant Pharmaceuticals, Zelapar, selegiline HCI, Parkinson's disease, Zydis]
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
HSMN NewsFeed,
12 Jul 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Eisai, AZILECT, rasagiline, Parkinson's disease]
Amarin Completes Target Patient Enrollment in North American Phase III Trial of Miraxion(TM) in Huntington's Disease
HSMN NewsFeed,
29 Jun 2006:
Biopharmaceuticals, Neurology[Amarin , Miraxion, Huntington's disease]
Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
HSMN NewsFeed,
28 Jun 2006:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
HSMN NewsFeed,
27 Jun 2006:
Biopharmaceuticals, FDA, Neurology[Novartis, Exelon , rivastigmine, Parkinson's disease, dementia]
Valeant Pharmaceuticals Receives FDA Approval of Zelapar(R) for Patients with Parkinson's Disease
HSMN NewsFeed,
15 Jun 2006:
Biopharmaceuticals, Neurology, FDA[Valeant Pharmaceuticals, Zelapar, selegiline, Parkinson's disease]
ACADIA Pharmaceuticals Announces Appointment of Roger G. Mills, M.D., as Executive Vice President, Development
HSMN NewsFeed,
5 Jun 2006:
Biopharmaceuticals[ACADIA Pharmaceuticals]
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Neurology[Antipodean Pharmaceuticals, MitoQ , mitoquinone, Parkinson's Disease]
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, FDA[Novartis, Exelon, rivastigmine, Parkinson's Disease]
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, FDA[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's Disease]
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, FDA[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's Disease]
Amarin Acquires Parkinson's Disease Drug Candidate
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, Acquisitions[Amarin Corp, apomorphine, Parkinson's Disease]
Boston Life Sciences, Inc. Solidifies Comprehensive Axon Regeneration Position with Children's Hospital Boston
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Neurology, Regenerative Medicine[Boston Life Sciences, Axon Regeneration]
Stem Cell Therapeutics Corp. Announces Issuance of Second US Patent
HSMN NewsFeed,
11 May 2006:
Regenerative Medicine[Stem Cell Therapeutics, stem cell]
Avicena Announces Phase III ALS Trial Results
HSMN NewsFeed,
9 May 2006:
Biopharmaceuticals, Neurology[Avicena Group, ALS-02, amyotrophic lateral sclerosis]
VSM reports progress on using MEG for diagnosing Alzheimer's and Parkinson's
HSMN NewsFeed,
8 May 2006:
Devices, Neurology[VSM MedTech, magnetoencephalography, Alzheimer's disease Parkinson's disease]
Questcor Announces the Acquisition of Doral(R) (quazepam)
HSMN NewsFeed,
5 May 2006:
Biopharmaceuticals, Neurology, Acquisitions[Questcor Pharmaceuticals, MedPointe, Doral , quazepam]
World-Renowned Safety Consultant Joy A. Cavagnaro Joins BrainStorm Cell Therapeutics
HSMN NewsFeed,
1 May 2006:
Regenerative Medicine, Personnel[BrainStorm Cell Therapeutics]
AVANIR Announces Neurodex Phase III Trial Results Published in Annals of Neurology
HSMN NewsFeed,
28 Apr 2006:
Biopharmaceuticals, Neurology[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect, emotional lability]
Medtronic to Pursue Major Clinical Trial of Deep Brain Stimulation as Depression Treatment
HSMN NewsFeed,
25 Apr 2006:
Devices, Neurosurgery[Medtronic, deep brain stimulation, neurostimulation, Kinetra, Soletra]
Medtronic Announces Clinical Trials Strategy for Neurological and Urological Therapies
HSMN NewsFeed,
24 Apr 2006:
Devices, Urology , Neurology[Medtronic, neurostimulation, needle ablation, Intrathecal baclofen]
Acuity Pharmaceuticals Continues Pipeline Expansion By Licensing a Novel Broad Spectrum Anti-Infective for Ophthalmic Use
HSMN NewsFeed,
20 Apr 2006:
Biopharmaceuticals, Ophthalmology, Licensing[Acuity Pharmaceuticals, Pathogenics, N-chlorotaurine]
Pathogenics, Inc. Licenses Worldwide Rights to Novel Anti-Infective Compound for Ophthalmological Use
HSMN NewsFeed,
19 Apr 2006:
Biopharmaceuticals, Ophthalmology, Licensing[Pathogenics, Acuity Pharmaceuticals, N-Chlorotaurine]
ACADIA Pharmaceuticals Announces Positive Clinical Trial Results Demonstrating That ACP-103 Increases Slow Wave Sleep
HSMN NewsFeed,
19 Apr 2006:
Biopharmaceuticals[ACADIA Pharmaceuticals, ACP-103, Slow Wave Sleep]
Reata Announces Licensing of Novel Class of Anti-Inflammatory Compounds; Drugs Have Broad Potential Across Multiple Therapeutic Areas
HSMN NewsFeed,
17 Apr 2006:
Biopharmaceuticals, Licensing[Reata Pharmaceuticals, tricyclic bis-enones]
Primitive Adult Stem Cells Found in Peripheral Blood
HSMN NewsFeed,
17 Apr 2006:
Regenerative Medicine[Moraga Biotechnology, Blastomere-Like Stem Cells, BLSC, stem cell]
Elekta to Deliver Sophisticated 3-D Brain Mapping Technology to Leading UK Institution
HSMN NewsFeed,
10 Apr 2006:
Devices, Neurology[Elekta, Neuromag , magnetoencephalography]
Pfizer to Expand Neuroscience Research With Acquisition of Biotech Company Rinat Neuroscience
HSMN NewsFeed,
6 Apr 2006:
Biopharmaceuticals, Mergers & Acquisitions[Pfizer, Rinat Neuroscience]
SCHWARZ PHARMA Presents Clinical Data on Rotigotine Transdermal Patch at the Annual Meeting of the American Academy of Neurology
HSMN NewsFeed,
6 Apr 2006:
Biopharmaceuticals, Neurology, Drug Delivery[SCHWARZ PHARMA, Rotigotine, Parkinson's Disease, transdermal patch]
Solstice Neurosciences, Inc. Releases New Data Confirming Effectiveness of Myobloc as a First-Line Therapy
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Neurology[Solstice Neurosciences, MYOBLOC, Botulinum Toxin Type B, Cervical Dystonia]
Pramipexole Significantly Improved Symptoms of Restless Legs Syndrome, New Studies Show
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim Pharmaceuticals, Restless Legs Syndrome, pramipexole]
Life Science Angels Invests in NeuroHealing Pharmaceuticals
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Venture Capital[Life Science Angels, NeuroHealing Pharmaceuticals]
AVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, Neurology, FDA[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect]
Neurology Academy Upgrades Deep Brain Stimulation in Latest Parkinson's Treatment Guidelines
HSMN NewsFeed,
3 Apr 2006:
Devices, Neurology[Medtronic, Parkinson's disease, deep brain stimulation]
Prestwick Pharmaceuticals Receives FDA Approvable Letter for XENAZINE(R) (Tetrabenazine) for Treatment of Chorea Associated with Huntington's Disease
HSMN NewsFeed,
31 Mar 2006:
Biopharmaceuticals, Neurology, FDA[Prestwick Pharmaceuticals, XENAZINE, tetrabenazine, Huntington's disease]
Avicena Compound Receives Orphan Drug Designation for Huntington's Disease
HSMN NewsFeed,
22 Mar 2006:
Biopharmaceuticals, Neurology, FDA[Avicena Group, HD-02, Huntington's disease]
Boston Life Sciences Ends ALTROPANE(R) POET-1 Phase III Trial Early to Evaluate Full Data Set
HSMN NewsFeed,
20 Mar 2006:
Biopharmaceuticals, Neurology[Boston Life Sciences, POET-1, ALTROPANE]
Avicena Announces Promising Phase II Results From Parkinson's Disease Trial
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Neurology[Avicena, PD-02, Parkinson's disease]
Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Sclerosis
HSMN NewsFeed,
8 Mar 2006:
Biopharmaceuticals, Neurology[Neurocrine Biosciences]
Kyowa Releases Results to Phase III Clinical Studies of an Anti-Parkinson's Disease Drug Istradefylline (KW-6002) Conducted Overseas
HSMN NewsFeed,
7 Mar 2006:
Biopharmaceuticals, Neurology[Kyowa, KW-6002, Istradefyllin, Parkinson's Disease]
Xyrem(R) (Sodium Oxybate) Now Available for the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Narcolepsy
HSMN NewsFeed,
6 Mar 2006:
Biopharmaceuticals, FDA[Jazz Pharmaceuticals, Xyrem, narcolepsy]
Stem Cell Therapy International Reports Successful Treatment of Multiple Sclerosis Patient With Stem Cell Transplantation Therapy
HSMN NewsFeed,
27 Feb 2006:
Regenerative Medicine, Neurology[Stem Cell Therapy International, multiple sclerosis, stem cell]
Valeant Pharmaceuticals Receives FDA Approval of Less-Restrictive Labeling for Tasmar(R)
HSMN NewsFeed,
22 Feb 2006:
Biopharmaceuticals, Neurology, FDA[Valeant Pharmaceuticals, Tasmar, tolcapone, Parkinson's disease]
Study Published in Neurology Shows Tetrabenazine Significantly Improves Debilitating Movement Disorder Caused by Huntington's Disease
HSMN NewsFeed,
14 Feb 2006:
Biopharmaceuticals, Neurology[Prestwick Pharmaceuticals, tetrabenazine, Huntington's Disease, chorea]
Altea Therapeutics and Teikoku Seiyaku Co. Ltd. Enter into an Agreement for the Development, Manufacture, and Commercialization in Japan of a New Transdermal Therapy for Parkinson's Disease
HSMN NewsFeed,
1 Feb 2006:
Biopharmaceuticals, Neurology, Drug Delivery, Licensing[Altea Therapeutics, Teikoku Seiyaku, Parkinson's Disease]
Neurologix Announces Appointment of Marc Panoff as Chief Financial Officer
HSMN NewsFeed,
25 Jan 2006:
Biopharmaceuticals, Personnel[Neurologix]
ACADIA Pharmaceuticals Announces Additional $10 Million Equity Investment by Sepracor
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals[ACADIA Pharmaceuticals, Sepracor]
ACADIA Pharmaceuticals Announces Appointment of David C. Furlano, Ph.D., as Vice President, Regulatory Affairs
HSMN NewsFeed,
9 Jan 2006:
Biopharmaceuticals, Personnel[ACADIA Pharmaceuticals]
Boston Life Sciences, Inc. Announces Appointment of Senior Vice President, Regulatory Affairs and Quality
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel[Boston Life Sciences]
Additional items found: The Network Archive contains
245 additional itemsParkinson\'s Disease
Public
Feeds 
Full text >>